Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Shareholders' Equity (Deficit)

v3.21.2
Condensed Statements of Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Receivables from Stockholder [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 126 $ 568,496 $ (572,599) $ (3,977)
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019 125,803        
Share-based compensation expense 793 793
Share-based compensation expense, shares 201        
Exercise of options 107 107
Exercise of options, shares 102        
Sales of common stock $ 18 8,930 8,948
Sales of common stock, shares 17,800        
Net loss (10,064) (10,064)
Ending balance, value at Sep. 30, 2020 $ 144 578,326 (582,663) (4,193)
Common Stock, Shares, Outstanding, Ending Balance at Sep. 30, 2020 143,906        
Beginning balance, value at Dec. 31, 2019 $ 126 568,496 (572,599) (3,977)
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019 125,803        
Ending balance, value at Dec. 31, 2020 $ 153 601,224 (6,135) (586,233) $ 9,009
Common Stock, Shares, Outstanding, Ending Balance at Dec. 31, 2020 152,926       152,926
Beginning balance, value at Jun. 30, 2020 $ 143 577,172 (579,837) $ (2,522)
Common Stock, Shares, Outstanding, Beginning Balance at Jun. 30, 2020 143,433        
Share-based compensation expense 449 449
Share-based compensation expense, shares        
Exercise of options 104 104
Exercise of options, shares 98        
Sales of common stock $ 1 601 602
Sales of common stock, shares 375        
Net loss (2,826) (2,826)
Ending balance, value at Sep. 30, 2020 $ 144 578,326 (582,663) (4,193)
Common Stock, Shares, Outstanding, Ending Balance at Sep. 30, 2020 143,906        
Beginning balance, value at Dec. 31, 2020 $ 153 601,224 (6,135) (586,233) $ 9,009
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2020 152,926       152,926
Share-based compensation expense $ 2 12,343 $ 12,345
Share-based compensation expense, shares 2,235        
Exercise of options $ 1 2,539 2,540
Exercise of options, shares 1,389        
Sales of common stock $ 8 122,885 6,135 129,028
Sales of common stock, shares 7,554        
Net loss (30,575) (30,575)
Ending balance, value at Sep. 30, 2021 $ 164 738,991 (616,808) $ 122,347
Common Stock, Shares, Outstanding, Ending Balance at Sep. 30, 2021 164,104       164,104
Beginning balance, value at Jun. 30, 2021 $ 164 736,159 (607,426) $ 128,897
Common Stock, Shares, Outstanding, Beginning Balance at Jun. 30, 2021 163,960        
Share-based compensation expense 2,810 2,810
Share-based compensation expense, shares 95        
Exercise of options 30 30
Exercise of options, shares 49        
Sales of common stock (8) (8)
Sales of common stock, shares        
Net loss (9,382) (9,382)
Ending balance, value at Sep. 30, 2021 $ 164 $ 738,991 $ (616,808) $ 122,347
Common Stock, Shares, Outstanding, Ending Balance at Sep. 30, 2021 164,104       164,104